For example, miR-140-3p was upregulated in the placentas of GDM patients, and was found to contribute to insulin signaling pathway impairment by directly targeting the insulin receptor and the insulin-like growth factor 1 receptor, inhibiting glucose uptake in HTR-8/SVneo and human umbilical vein endothelial cells [12]. The gene discussed is INS; the disease is gestational diabetes.